Your browser doesn't support javascript.
loading
Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial.
Garcia-Huidobro, Diego; Iturriaga, Carolina; Perez-Mateluna, Guillermo; Fajuri, Paula; Severino, Nicolás; Urzúa, Marcela; Fraga, Juan Pablo; de la Cruz, Javiera; Poli, Cecilia; Castro-Rodríguez, José A; Fish, Eleanor; Borzutzky, Arturo.
Afiliação
  • Garcia-Huidobro D; Department of Family Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Iturriaga C; Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN, USA.
  • Perez-Mateluna G; Translational Allergy and Immunology Laboratory, Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Fajuri P; Translational Allergy and Immunology Laboratory, Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Severino N; Translational Allergy and Immunology Laboratory, Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Urzúa M; Pharmacology and Toxicology ProgramSchool of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Fraga JP; Translational Allergy and Immunology Laboratory, Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • de la Cruz J; Translational Allergy and Immunology Laboratory, Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Poli C; Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Castro-Rodríguez JA; Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Fish E; Department of Pediatric Pulmonology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Borzutzky A; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Clin Drug Investig ; 43(6): 447-461, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37347370
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Clin Drug Investig Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Chile País de publicação: Nova Zelândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Clin Drug Investig Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Chile País de publicação: Nova Zelândia